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Even in the year 2016, tuberculosis is still worldwide problem which is addressed by 
many national and supra-national organizations trying to eliminate it. It burdens the most 
developing countries which don’t usually have the opportunity to access the potential 
of modern medicine to its full extent. In relation to ineffective treatment, there grows prevalence 
of tuberculosis, which can’t be managed by standard treatment. There is an urgent need to find 
new compounds and change structures of current antituberculars, which will help us defeat 
multi-drug resistant M. tuberculosis. 
The objective of my work was to find out the influence of inversion of the amidic group 
in derivatives of pyrazin-2-carboxylic acid (-CO-NH- to -NH-CO-) and their efficacy and 
toxicity. 
In the theoretical part I focused on resuming all the basic facts about tuberculosis and 
its causing agent, about possibilities in prevention and diagnostics 
as well as the antituberculars, both used and currently tested, which can help us in the future. 
In the experimental part I wrote down the reactions and procedures, which were used to 
prepare seventeen derivatives of N-(5-chloropyrazin-2-yl)benzamides and two derivatives of 
N-(pyrazin-2-yl)benzamides, which were prepared form either reaction of benzoylchlorides 
with amines, or, in one case, by coupling reaction of substituted benzoic acid with amine in 
presence of N,N’-carbonyldiimidazole. New compounds were characterized by their melting 
points, elementar analysis, NMR and IR spectres. 
Afterwards, each compound had its in vitro antimycobacterial, antibacterial 
and antifungal efficacy tested. Those compounds, that showed promising antimycobacterial 
efficacy, were subjected to in vitro cytotoxicity tests. Overall, there weren’t many active new 
structures except for four molecules which were efficacious on M. tuberculosis and one 
efficient antibacterial compound. 
